NeuralDx represents a breakthrough in the fast and objective diagnosis of psychiatric and neurological disorders.

In countries of all income levels, people who are depressed are often not correctly diagnosed, and others who do not have the disorder are too often misdiagnosed and prescribed antidepressants.
— World Health Organisation

Our Mission

One in four people will suffer from a serious psychiatric or neurological disorder, in their lifetime, such as Alzheimer’s, Parkinson’s, Major Depression, Bipolar Disorder or Schizophrenia. Our patented EVestG technology provides fast, objective diagnosis of those disorders, allowing patients access earlier treatment.

EVestG allows clinicians to diagnose a broad range of neurological and psychiatric disorders with the necessary accuracy and objectivity.

EVestG will provide the world’s clinicians with the first ever quick, painless, non-invasive, low-cost and objective diagnostic tool.